We help shape winning products and maximize their value throughout the product life cycle.

Our team members are experts in commercial strategy, with a focus on helping development-stage therapies lay the groundwork for commercial success.

Our work also extends to in-line products, as we help clients anticipate and manage evolving market situations throughout the life cycle.

New Product Planning

Maximizing a product’s commercial value starts early in development. Blue Matter is the ideal partner to help customers prepare their products for success. Offerings include:

  • Competitive / Market Assessment
  • Indication Prioritization
  • “Winning Label” / Target Product Profile Development
  • Positioning and Key Message Strategy
  • Product Development Strategy
  • Clinical Program Design
  • Market Access Strategy
  • Revenue Forecasts

Launch Strategy and Planning

Launch can set a product’s revenue trajectory for years to come, and product teams can’t take chances.
Blue Matter has successfully completed nearly 300 launch-related projects in the last 5 years alone.
Our experience spans:

  • Global, US, and EU Launches
  • Oncology, Rare Diseases, a range of Specialty Products, and more
  • Small Molecules, Biologics, and Others
  • NMEs and Line Extensions

Our comprehensive launch services leverage our data set of more than 500 biopharma-specific launch deliverables across 16 functional areas and sub-teams. It’s complete with timelines, industry benchmarks, and management tools. Offerings include:

  • Launch Strategy
  • Launch Operational Planning
  • Launch Readiness Reviews
  • Launch Roadmaps and Project Management
  • Competitive Readiness

Brand Strategy and Planning

The effort to maximize peak commercial performance continues throughout the product life cycle. Our goal is to help customers achieve peak commercial performance sooner and maintain it longer. We help optimize positioning and messaging, market access, customer engagement, and more.

  • Brand Planning
  • Life Cycle Strategy


Contact Us to learn more.